Physician profile
Christopher J Elder
NPI 1033553979
$41,027.40
in general payments reported to CMS, 2019-2025
6 companies · $14K in 2025
The $14K reported for 2025 was more than what 92% of Epilepsy providers received nationally (typical 2025 total: $366).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2022: $105 · 2023: $17K · 2024: $9,488 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $35K · Food and Beverage: $2,435 · Consulting Fee: $1,838 · Travel and Lodging: $1,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $34,600.00 |
| Food and Beverage | $2,434.67 |
| Consulting Fee | $1,837.50 |
| Travel and Lodging | $1,750.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $39,943.97 | 2023-2025 | Xcopri |
| Neuropace, INC. | $401.34 | 2022-2025 | |
| Ucb, INC. | $242.71 | 2019-2025 | Fintepla |
| Jazz Pharmaceuticals INC. | $242.53 | 2019-2025 | |
| Greenwich Biosciences, INC. | $140.00 | 2019 | |
| Medtronic, INC. | $56.85 | 2024-2025 | Percept Pc Brainsense |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Elder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.